Integra LifeSciences closed its acquisition of Metasurg's product portfolio.
The Latest
Is X-Stop better or worse than minimally invasive decompression?
Here are updates on spine device company stock from five key companies.
Wright Medical Group expects 2014 sales to increase 23 percent to $298 million, according to the company's preliminary fourth quarter and full year financial report.
MiMedx reported full year revenue growth at around $117 million.
Bacterin reported their fourth quarter and total year preliminary financial results for 2014.
Amedica is taking a comprehensive business review to heart, hoping it will help improve the company's financial performance, increase operational efficiency and strengthen the value proposition.
After a year of delaying financial reports, Orthofix released expectations for the 2014 net sales, which are reported at $397 million to $401 million.
The latest publication from the Spine Patient Outcomes Research Trials shows eight-year outcomes data for patients with symptomatic lumbar stenosis. The results were published in Spine.
The Food and Drug Administration granted 510(k) clearance in December 2014.
